Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2629 (LINC02629) is a lncRNA gene located in the human genome, mapped by HGNC and NCBI. It does not encode a protein, is not classified as a receptor, enzyme, or other therapeutic target class, and remains largely uncharacterized regarding biological function or disease association. Its known synonyms include TCONS_00017811. To date, there is no evidence of direct involvement with drugs, disease roles, biomarker utility, or therapeutic challenges. It is a member of the intergenic lncRNA gene family, and its expression profile, functional significance, and clinical relevance require further study.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2629 (LINC02629).